NYSEAMERICAN:CVRS - Corindus Vascular Robotics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.04 +0.03 (+2.97 %)
(As of 07/18/2018 04:35 AM ET)
Previous Close$1.01
Today's Range$0.98 - $1.07
52-Week Range$0.66 - $2.05
Volume1.23 million shs
Average Volume1.11 million shs
Market Capitalization$272.68 million
P/E RatioN/A
Dividend YieldN/A
Beta18.81
Corindus Vascular Robotics logoCorindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

Receive CVRS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVRS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CVRS
CUSIPN/A
Phone+1-508-6533335

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-323.84%
Return on Equity-110.93%
Return on Assets-88.11%

Miscellaneous

EmployeesN/A
Outstanding Shares188,790,000
Market Cap$272.68

The Truth About Cryptocurrencies

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) released its quarterly earnings results on Tuesday, May, 8th. The medical equipment provider reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.03. The medical equipment provider earned $1.49 million during the quarter, compared to the consensus estimate of $3.20 million. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%. View Corindus Vascular Robotics' Earnings History.

What price target have analysts set for CVRS?

2 brokers have issued 12 month target prices for Corindus Vascular Robotics' stock. Their forecasts range from $2.00 to $2.00. On average, they expect Corindus Vascular Robotics' share price to reach $2.00 in the next year. This suggests a possible upside of 92.3% from the stock's current price. View Analyst Ratings for Corindus Vascular Robotics.

What is the consensus analysts' recommendation for Corindus Vascular Robotics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Are investors shorting Corindus Vascular Robotics?

Corindus Vascular Robotics saw a decrease in short interest during the month of June. As of June 29th, there was short interest totalling 13,155,722 shares, a decrease of 9.2% from the June 15th total of 14,493,792 shares. Based on an average trading volume of 2,313,653 shares, the short-interest ratio is presently 5.7 days. Currently, 16.1% of the company's shares are sold short. View Corindus Vascular Robotics' Current Options Chain.

Who are some of Corindus Vascular Robotics' key competitors?

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the folowing people:
  • Mr. Mark J. Toland, CEO, Pres & Director (Age 48)
  • Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 48)
  • Mr. Tal Wenderow, Co-Founder and Exec. VP of International & Bus. Devel.
  • Mr. Doug Teany, Chief Operating Officer
  • Ms. Nora Dutta, VP of HR

Has Corindus Vascular Robotics been receiving favorable news coverage?

News headlines about CVRS stock have been trending somewhat positive on Wednesday, according to Accern. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Corindus Vascular Robotics earned a media sentiment score of 0.07 on Accern's scale. They also assigned headlines about the medical equipment provider an impact score of 46.77 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of CVRS stock can currently be purchased for approximately $1.04.

How big of a company is Corindus Vascular Robotics?

Corindus Vascular Robotics has a market capitalization of $272.68 million.

How can I contact Corindus Vascular Robotics?

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.


MarketBeat Community Rating for Corindus Vascular Robotics (NYSEAMERICAN CVRS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  202 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  468
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.